News

With so few Alzheimer’s drugs available, repurposing medications approved for other conditions could be the key to tackling ...
The NHS explains that Alzheimer's disease is believed to be driven by an abnormal build-up of two proteins, amyloid and tau. These deposits often develop around our existing brain cells, forming ...
Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...
This ancient herbal supplement is known for its potential to enhance memory and mental clarity by improving blood circulation ...
The fungi within our bodies may have a much greater effect on our health than we've long given them credit for.
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Here's what cinnamon is, how it can boost your health and when it’s time to ease up on how much you're eating.
There's no magic formula for knowing when —or if — to euthanize a beloved pet, but preparation and trusting your gut can help ...
Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...
Key Points Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street.However, the company ...
A POPULAR nerve and back pain medicine has been linked to an increased risk of dementia by scientists. The risk was ...